News

Podcast: Dr. Shelly Batra Working to Eliminate TB in India

Operation ASHA is an NGO based out of New Delhi, India and Chicago, USA

Listen to Shelly Batra Podcast

Summary: Shelly Batra is a renowned gyn & obs surgeon in New Delhi. She has a deep desire to serve the community. She has worked pro-bono for dissemination of medical information with many television stations and newspapers and written two books for Penguin Publishers.

After providing health care in urban slum communities for two decades, Shelly co-founded Operation ASHA with the mission of eradicating tuberculosis. It has now become one of India”s largest nonprofits in TB control, serving a population of 1 million. Not only that, it is respected world-wide for its performance in TB treatment. Its success is due to its innovative treatment approach: delivering the services to the doorsteps of the disadvantaged. As a result, Operation ASHA has dramatically improved patient outcomes, successfully overcoming the many barriers to treatment, including destitution, poverty, illiteracy, and poor environmental conditions.

For the past two decades, she has been providing consultations and carrying out free surgeries for the needy. She organized 60-70 free surgeries every year and provided free consultation to thousands.

More News
22 Jul 2024
The National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) has issued a $30.8 million grant to the Preclinical Design and Clinical Translation of TB Regimens (PreDiCTR) consortium , a new consortium co-led by investigators from Weill Cornell Medicine; the...
27 Jun 2024
On May 17, the World Health Organization (WHO) released its updated  Bacterial Priority Pathogens List (BPPL) 2024 and for the first time in its history it included a drug resistant strain of Mycobacterium tuberculosis. Along with three other new families of antibiotic-resistant bacterial pathogens...
19 Mar 2024
For World TB Day 2024, the WGND is spotlighting a monumental achievement in TB drug research and development: the Global TB Drug Pipeline has never been bigger than it is today. The number of drug candidates being clinically evaluated for use in the treatment of adult pulmonary TB has surpassed...